Effective Way To Ensure Early Statistical Deliveries

Situation

A biopharmaceutical company had a first-in-human study in patients with solid tumors.

Challenge

They needed to provide regular and timely reports to the Safety Review Committee for dose decisions, to support rapid study completion.

Solution

Cmed specializes in innovative technical solutions for sponsors. By applying previous experience of first-in-human studies, Cmed was able to provide a solution.